BeStock  
Stocks › Biotechnology › ETRA

ELECTRA THERAPEUTICS INC ETRA

US equityMarket cap rank #3667Biotechnology
$9.16 −$0.66 (-6.72%)
Pre-market · Oct 8, 8:10 am ET · After hours $9.16 0.00%
Open$9.72
Prev close$9.82
Day range$8.92 – $9.73
Volume407.3K
Market cap$559.68M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$0.00
Operating profit-$61.89M-135.2% YoY
Net profit-$61.98M-150.0% YoY
Diluted EPS-$1.80-186.4% YoY

Profitability & balance sheet

Return on assets-89.4%
Current ratio7.37
Liabilities / assets125.1%
Cash & investments$97.73M
Total debt$1.16M
Net cash (debt)$96.57M

Balance sheet

Line item 2026 Q2 2025 Q4 2025 ANNUAL 2024 ANNUAL
-Current Capital Lease Obligation $827,000.00 $605,000.00 $605,000.00 $0.00
Total Non-Current Liabilities $119.64M $119.97M $119.97M $118.49M
-Cash and Cash Equivalents $66.51M $33.01M $33.01M $14.79M
-Long Term Capital Lease Obligation $1.16M $1.48M $1.48M $0.00
Retained Earnings -$221.89M -$172.98M -$172.98M -$111.00M
Convertible preferred securities $118.49M $118.49M $118.49M $118.49M
Total Equity -$26.77M -$30.33M -$30.33M -$103.26M
Stockholders' Equity -$26.77M -$30.33M -$30.33M -$103.26M
Capital Stock $192.69M $133.12M $133.12M $0.00
-Common Stock $0.00 $0.00 $0.00 $0.00
-Preferred Stock $192.69M $133.12M $133.12M $0.00
Additional Paid-In Capital $2.45M $9.52M $9.52M $7.74M
Gains/Losses Not Affecting Retained Earnings -$13,000.00 $21,000.00 $21,000.00 $1,000.00
Total Assets $106.50M $99.37M $99.37M $19.42M
Total Current Assets $100.36M $95.49M $95.49M $19.42M
Cash and Cash Equivalents & Short-Term Investments $97.73M $86.52M $86.52M $15.79M
Total Non-Current Assets $6.14M $3.88M $3.88M $0.00
Short-Term Debt and Capital Lease Obligation $827,000.00 $605,000.00 $605,000.00 –
Total Liabilities $133.27M $129.69M $129.69M $122.68M
Current Accrued Expenses $6.79M $3.03M $3.03M $1.40M
-Other Receivables $264,000.00 $220,000.00 $220,000.00 $55,000.00
Prepaid Assets $1.98M $8.57M $8.57M $3.42M
Other Current Assets $392,000.00 $179,000.00 $179,000.00 $165,000.00
Total Current Liabilities $13.63M $9.73M $9.73M $4.20M
Receivables $264,000.00 $220,000.00 $220,000.00 $55,000.00
Net PPE $2.41M $2.78M $2.78M $0.00
-Accounts Payable $4.61M $4.08M $4.08M $1.54M
Payables $4.61M $4.08M $4.08M $1.54M
-Short Term Investments $31.22M $53.51M $53.51M $998,000.00
Other Non-Current Assets $3.73M $1.10M $1.10M –
Long Term Debt and Capital Lease Obligation $1.16M $1.48M $1.48M $0.00
-Gross PPE $2.41M $2.78M $2.78M $0.00

Cash flow

Line item 2025 ANNUAL 2024 ANNUAL
Operating Cash Flow -$60.48M -$26.00M
Net Preferred Stock Issuance $91.68M $0.00
Ending Cash Balance $33.01M $14.79M
Net Change in Cash $18.22M $3.70M
Beginning Cash Balance $14.79M $11.09M
Free Cash Flow -$61.22M -$26.00M
Net Cash Flow from Continuing Financing Activities $131.68M $0.00
Financing Cash Flow $131.68M $0.00
Net Investment Purchase and Sale -$52.25M $29.70M
Net cash flow from continuing operations -$60.48M -$26.00M
Net Income from Continuing Operations -$61.98M -$24.79M
Depreciation & Depletion & Amortization $61,000.00 $0.00
Other Non-Cash Items $1.65M –
Change in Working Capital -$1.74M -$2.80M
-Change in Receivables -$165,000.00 $38,000.00
-Change in Prepaid Assets -$5.17M -$3.26M
-Change in Payables and Accrued Expense $4.93M $417,000.00
-Change in Other Current Assets -$1.10M $0.00
-Change in Other Current Liabilities -$239,000.00 $0.00
Net cash flow from investing -$52.98M $29.70M
Net Cash Flow from Continuing Investing Activities -$52.98M $29.70M
Net PPE Purchase and Sale -$733,000.00 $0.00
Net Issuance Payments Of Debt $40.00M $0.00

Income statement

Line item 2025 ANNUAL 2024 ANNUAL
Diluted EPS -$1.80 -$0.63
Selling and Admin Expenses $11.50M $7.05M
Operating Expense $61.89M $26.32M
Total Operating Revenue $0.00 $0.00
Pretax Profit -$61.98M -$24.79M
Other Non-Operating Income (Expenses) -$15,000.00 $7,000.00
-General & Admin Expense $11.50M $7.05M
Research & Development $50.39M $19.27M
Basic EPS -$1.80 -$0.63
Net Income to Common Stockholders -$61.98M -$24.79M
Net Income to Parent Company -$61.98M -$24.79M
Profit from Continuing Operations -$61.98M -$24.79M
Net Profit -$61.98M -$24.79M
Other Income (Expense) -$15,000.00 $7,000.00
Non-Operating Interest Expense $1.43M $0.00
Non-Operating Interest Income $1.36M $1.52M
Net Non-Operating Interest Income (Expense) -$71,000.00 $1.52M
Operating Profit -$61.89M -$26.32M

Discussion

No comments yet — be the first to weigh in on ETRA.

Leave a comment

Scroll to Top